4//SEC Filing
Windham-Bannister Susan Richards 4
Accession 0001818382-23-000086
CIK 0001818382other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:10 PM ET
Size
5.4 KB
Accession
0001818382-23-000086
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Windham-Bannister Susan Richards
Director
Transactions
- Award
Stock Options (right to buy)
2023-06-15+8,500→ 8,500 totalExercise: $3.35Exp: 2033-06-15→ Common Stock (8,500 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on June 15, 2024, after which 1/48 of the option will become exercisable on the 15th of each month through June 15, 2027.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0001713760
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:10 PM ET
- Size
- 5.4 KB